Mark Hamann to HIV-1
This is a "connection" page, showing publications Mark Hamann has written about HIV-1.
Connection Strength
0.830
-
Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity. Bioorg Med Chem. 2006 Dec 15; 14(24):8495-505.
Score: 0.238
-
New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. J Med Chem. 2004 Jul 01; 47(14):3512-7.
Score: 0.203
-
Manadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1. J Am Chem Soc. 2003 Nov 05; 125(44):13382-6.
Score: 0.194
-
Chemical transformation and biological studies of marine sesquiterpene (S)-(+)-curcuphenol and its analogs. Biochim Biophys Acta. 2007 Nov; 1770(11):1513-9.
Score: 0.063
-
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod. 2006 Jul; 69(7):1034-40.
Score: 0.058
-
Mololipids, a new series of anti-HIV bromotyramine-derived compounds from a sponge of the order verongida. J Nat Prod. 2000 Apr; 63(4):501-3.
Score: 0.038
-
Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea. J Nat Prod. 2000 Jan; 63(1):29-33.
Score: 0.037